# Open Orphan plc

- Link: https://www.directorstalkinterviews.com/company/open-orphan-plc/orph.l
- Published: 2020-10-29T16:02:04+00:00
- Author: Giles

**Open Orphan plc** (LON: ORPH) was a rapidly growing niche CRO pharmaceutical services
company which was a world leader in the testing of vaccines and antivirals through
the use of human challenge clinical trials.

Open Orphan comprosed of two commercial specialist CRO services businesses; hVIVO
and Venn Life Sciences.

Open Orphan now trades on the London Stock Exchange as [hVIVO plc](https://www.directorstalkinterviews.com/company/hvivo-plc/hvo.l)

**hVIVO**

hVIVO is the world leader in the testing of vaccines and antivirals using human 
challenge study models. It is a trusted partner and industry-leading clinical development
services business pioneering human disease models based upon viral challenge.

Run from Europe’s only 24-bedroom quarantine clinic with onsite virology lab in 
London, hVIVO use human challenge studies to establish early proof-of-concept, hVIVO’s
clinical trial platform can accelerate drug and vaccine development in respiratory
and infectious disease.

hVIVO supports product development for customers developing antivirals, vaccines
and respiratory therapeutics.  Click here to view the [hVIVO company profile](https://www.directorstalkinterviews.com/company/hvivo-plc/hvo.l).

![Open Orphan](https://www.directorstalkinterviews.com/wp-content/uploads/2020/10/
Open-Orphan-hVIVO-1024x213.jpg "Open Orphan plc (orph)")

**Venn Life Sciences**

Venn Life Sciences is an Integrated Drug Development Partner offering a unique combination
of drug development expertise, clinical trial design and execution services. This
enables us to create, plan and execute drug and medical device development programs
effectively and seamlessly for our clients. 

Venn has teams across both early and late phase research, late phase teams specialise
in multi-site cross cultural clinical trials with unique knowledge of local and 
EU regulations. Over Venn’s 25 year history we have built up substantial therapeutic
and study experience, contributing to the efficient management of sites, budgets
and communication channels with all parties involved. Venn is renowned for its hands-
on approach and consistent delivery of high quality work on time and on budget.

![Open Orphan](https://www.directorstalkinterviews.com/wp-content/uploads/2020/10/
Open-Orphan-Venn-Life-Sciences-1024x213.jpg "Open Orphan plc (orph)")

Below you will find the 5 day trade history, latest news, interviews and Open Orphan
share price.

       Please leave this field empty

### **Don't miss out** --->

**Receive this company's news, reports, interviews in your inbox, as we post it.**

_We don’t spam! Read our [privacy policy](https://www.directorstalkinterviews.com/about-us/privacy-policy)
for more info._

Please check your inbox or spam folder now to confirm your subscription.
